Crossing survival curves of KEYNOTE-177 illustrate the rationale behind combining immune checkpoint inhibition with chemotherapy. Issue 6 (June 2022)

Record Type:: Journal Article
Title:: Crossing survival curves of KEYNOTE-177 illustrate the rationale behind combining immune checkpoint inhibition with chemotherapy. Issue 6 (June 2022)
Main Title:: Crossing survival curves of KEYNOTE-177 illustrate the rationale behind combining immune checkpoint inhibition with chemotherapy
Authors:: Bomze, David
Mutti, Luciano
Goldman, Adam
Markel, Gal
Meirson, Tomer
Abstract:
Is Part Of:: Lancet oncology. Volume 23:Issue 6(2022)
Journal:: Lancet oncology
Issue:: Volume 23:Issue 6(2022)
Issue Display:: Volume 23, Issue 6 (2022)
Year:: 2022
Volume:: 23
Issue:: 6
Issue Sort Value:: 2022-0023-0006-0000
Page Start:: e245
Page End:
Publication Date:: 2022-06
Subjects:: Oncology -- Periodicals
Neoplasms -- Periodicals
Cancérologie -- Périodiques
Oncologie
Oncology
Periodicals
Electronic journals
616.994005
Journal URLs:: http://www.sciencedirect.com/science/journal/14702045 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S1470-2045(22)00258-3 ↗
Languages:: English
ISSNs:: 1470-2045
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5146.090000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 21573.xml